Daniel Char
General Counsel bei IMMUNOGEN, INC.
Profil
Daniel S.
Char is currently the Secretary, Chief Legal Officer & Senior VP at ImmunoGen, Inc. He previously worked as an Associate General Counsel at Biogen, Inc. from 1995 to 2006, as a Senior Associate General Counsel at Idenix Pharmaceuticals LLC from 2006 to 2007, as the Secretary, Vice President & General Counsel at Targanta Therapeutics Corp.
from 2008 to 2009, and as the Associate General Counsel-Commercial at Smith + Nephew, Inc. from 2009 to 2018.
He also briefly served as the General Counsel at Evelo Biosciences, Inc. in 2018.
Mr. Char received his undergraduate degree from Tufts University in 1983 and his graduate degree from Harvard Law School in 1986.
Aktive Positionen von Daniel Char
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOGEN, INC. | General Counsel | 21.11.2022 |
Ehemalige bekannte Positionen von Daniel Char
| Unternehmen | Position | Ende |
|---|---|---|
Smith + Nephew, Inc.
 Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Corporate Officer/Principal | 01.03.2018 |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | General Counsel | 01.03.2009 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2006 |
| EVELO BIOSCIENCES, INC. | General Counsel | - |
Ausbildung von Daniel Char
| Tufts University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
Smith + Nephew, Inc.
Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Health Technology |
